![]() Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. | ||
Founding Date | Founding Date 2019 | Founding Date 2015 | Founding Date 2002 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations HQ | Locations Stevenage, GB HQ Boston, US New York, US | Locations Illkirch-Graffenstaden, FR HQ New York, US |
Employees | Employees 284% increase | Employees 122 | Employees 1133% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 289.3m | Total funding raised $ 3.2m |

Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View companyPolyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View company